Medania Purwaningrum

Medania Purwaningrum

Auto-generated profile, based on publicly available information

Medania Purwaningrum

Universitas Gadjah Mada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
MPMedania Purwaningrum
Medania Purwaningrum
NJNabila Syarifah Jamilah
Nabila Syarifah Jamilah
SPSteven Dwi Purbantoro
Steven Dwi Purbantoro
CSChenphop Sawangmake
Chenphop Sawangmake
SNSirirat Nantavisai
Sirirat Nantavisai
Purwaningrum M, et al. J Vet Sci. 2021 Aug;22(6):e74. https://doi.org/10.4142/jvs.2021.22.e74

1 January 2025 in Open Veterinary Journal
Verified
Journal Article
Open access
PDF file
AWArif Wicaksono
Arif Wicaksono
AHAris Haryanto
Aris Haryanto
AIAlek Ibrahim
Alek Ibrahim
ASAnggita Suryandari
Anggita Suryandari
RPRana Ayuningtyas Adhi Puspita
Rana Ayuningtyas Adhi Puspita
MPMedania Purwaningrum
Medania Purwaningrum
Background: Scrapie is a deadly neurodegenerative transmissible spongiform encephalopathy (TSE) that affects sheep and goats. TSEs are a consequence of polymorphisms of the prion protein gene PRNP, which result in misfolded prion proteins. They are transmitted through contact with the abnormal proteins (prions). Currently, there is no data regarding the identification of PRNP variability in Indonesian sheep breeds. Aim: This study aims to identify variants of the PRNP gene and classify the risk of scrapie disease genotypically in thin-tailed and fat-tailed sheep. Methods: DNA isolates from the blood samples of thin-tailed (ET) and fat-tailed (EG) sheep were amplified with the forward primer 5'-AAGCCACATAGGCAGTTGGA-3' and the reverse primer 5'-GAGACACCACCACTACAGGG-3'. A total of ten samples of PCR products were sequenced and analyzed with MEGA v.11 software. The data were multiply aligned with comparison samples from GenBank. Results: We identified 10 nucleotide variations and 11 single-nucleotide polymorphisms (SNPs) at sites 379, 380, 566, 691, and 711. Four codon haplotypes were identified, namely G127A, G127S, G127V, and Q189L, as well as six genotypic variations at codon 127 and two at codon 189. All ET and EG samples had the scrapie codon A136L141R154Q171. Conclusion: The lack of resistant genotypes and protective alleles in the sheep in this study rendered them less genetically resistant to classical scrapie and more susceptible to atypical scrapie. This is the first study on the identification of PRNP gene variations in sheep in Indonesia. Our results suggest the need for further PRNP research in sheep, especially in Indonesia, to anticipate the risk of a scrapie outbreak and determine the relationship between PRNP variants and phenotypic characteristics of sheep.

27 August 2026 in Veterinary World
Verified
Journal Article
Open access
PDF file
YDYustina Septi Dyanitha
Yustina Septi Dyanitha
AHAris Haryanto
Aris Haryanto
TBTeguh Budipitojo
Teguh Budipitojo
DADito Anggoro
Dito Anggoro
CSChenphop Sawangmake
Chenphop Sawangmake
MPMedania Purwaningrum
Medania Purwaningrum
Background and Aim: Mesenchymal stem cell-derived exosomes (MSC-Exos) have emerged as promising cell-free therapeutics because they retain the regenerative and immunomodulatory properties of their parent cells while minimizing the risks associated with cell transplantation. Canine dental pulp stem cell-derived exosomes (cDPSC-Exos) represent an attractive veterinary regenerative platform because dental pulp is readily accessible through minimally invasive procedures. However, their molecular composition and xenogeneic therapeutic potential remain largely unexplored. This study aimed to characterize canine dental pulp stem cells (cDPSCs) and their derived exosomes, define the proteomic profile of cDPSC-Exos, and evaluate their safety and therapeutic potential for post-castration wound-healing in cats. Materials and Methods: cDPSCs were isolated from canine dental pulp and characterized according to mesenchymal stem cell (MSC) criteria using morphology, colony-forming ability, proliferation, trilineage differentiation, and reverse transcription-quantitative polymerase chain reaction analysis of MSC surface and stemness markers. Exosomes were isolated from conditioned medium and characterized by nanoparticle tracking analysis and CD9 expression. High-resolution mass spectrometry was used for proteomic profiling, followed by functional pathway and protein interaction analyses. A randomized controlled pilot study involving six healthy male cats (n = 3/group) compared topical cDPSC-Exos gel (3.3 × 10⁸ particles/g) with Bioplacenton® following castration. Wound-healing was evaluated using macroscopic wound scores, hematological parameters, and laser speckle contrast imaging. Results: The isolated cDPSCs fulfilled the defining characteristics of MSCs, including multilineage differentiation and expression of MSC-associated markers. cDPSC-Exos exhibited typical exosome characteristics, with a mean particle diameter of 111 ± 24 nm. Proteomic analysis identified 312 proteins, including 22 proteins associated with inflammation regulation, angiogenesis, extracellular matrix organization, cell migration, and tissue remodeling. Western blot analysis confirmed the presence of vimentin and β-actin, supporting the proteomic findings. Topical administration of cDPSC-Exos was well tolerated, without adverse reactions, and significantly improved wound redness, swelling, and pain scores during early healing (p < 0.05), while hematological variables and tissue perfusion remained comparable to the positive control. Conclusion: This study provides the first comprehensive proteomic characterization of cDPSC-Exos and the first evidence supporting their xenogeneic application in feline post-castration wound-healing. The findings demonstrate that cDPSC-Exos constitute a safe and promising cell-free regenerative therapy capable of modulating early wound repair through multiple biological pathways. Larger controlled studies are warranted to validate their clinical efficacy and optimize therapeutic protocols. Keywords: angiogenesis, cell-free therapy, dental pulp stem cells, exosomes, proteomics, regenerative medicine, wound-healing, xenogeneic therapy.

1 October 2025 in Jurnal Medik Veteriner
Verified
Journal Article
Open access
PDF file
MPMedania Purwaningrum
Medania Purwaningrum
AHAris Haryanto
Aris Haryanto
YKYohanna Kayanaveda
Yohanna Kayanaveda
CSChenphop Sawangmake
Chenphop Sawangmake
Equine mesenchymal stem cells (MSCs) are promising for bone tissue engineering (BTE) because of their capabilities of differentiating into osteoblasts. Cell therapy using equine MSCs has been introduced. Recently, dental-derived MSCs have gained significant attention due to their capabilities and ease of collection with minimally invasive collection methods. Dental stem cells show high plasticity, accessibility, and applicability for regenerative medicine and are thus considered alternative sources of MSCs. This study evaluated the characterization, osteogenic differentiation potential, and migration assay of equine dental pulp stem cells (eDPSCs) as compared with equine periodontal ligament stem cells (ePDLSCs). Equine dental stem cells from eDPSCs and ePDLSCs (n = 4) were isolated and expanded to passage 3. The morphology, colony-forming capability, cell proliferation assay, stemness and surface markers, trilineage differentiation potential, and migration assay were investigated in vitro. Both eDPSCs and ePDLSCs exhibited a fibroblast-like morphology; showed a colony-forming capability; were able to proliferate based on the results of the cell proliferation assay; expressed stemness and surface markers (NANOG, CD29, CD44, CD90, CD18); maintained the ability to differentiate into osteocytes, chondrocytes, and adipocytes and demonstrated migration capacity based on the migration assay. Surprisingly, ePDLSCs showed significant differences in matrix mineralization, quantification of Alizarin Red staining by cetylpyridinium chloride, and mRNA expression of the osteogenic marker RUNX2. ePDLSCs and eDPSCs may be better alternative MSCs than dental stem cells for the further design of therapeutic regimens for BTE and wound-healing therapy.

1 January 2026 in Veterinary Medicine International
Verified
Journal Article
Open access
PDF file
RDRuchianasari Deliaputri
Ruchianasari Deliaputri
TBTeguh Budipitojo
Teguh Budipitojo
AHAris Haryanto
Aris Haryanto
MPMedania Purwaningrum
Medania Purwaningrum
Background and Aim: Exosome‐based cell‐free therapies have shown significant potential to enhance diabetic ulcer healing. Exosomes derived from equine periodontal ligament stem cells (ePDLSCs) offer a viable alternative for regenerative wound‐healing treatments. This study aimed to characterize and analyze the protein composition of these exosomes and assess their efficacy in treating diabetic wounds in vivo. Materials and Methods: This study employed RT‐qPCR and Nanoparticle Tracking Analysis (NTA) to isolate and characterize ePDLSCs–exosomes, western blot analysis of ePDLSCs–exosomes, proteomic protein profile analysis of ePDLSCs–exosomes using high‐resolution mass spectrometry (HRMS), western blot analysis for ACTB and VIM, potential protein profiling with proteomic analysis data associated with wound healing (Reactome, gene ontology [GO], KEGG pathways analysis), and assessment of ePDLSCs–exosome gel in vivo wound healing of diabetic ulcer wounds. Results: The findings of this study reveal that exosomes derived from ePDLSCs, as shown by NTA, had a size distribution of approximately 114 ± 39 nm and expressed the exosome surface marker CD9. ePDLSCs–exo contained 35 proteins with potential involvement in wound healing, with the largest PSMs being annexin 2 (ANXA2), actin beta (ACTB), and vimentin (VIM), as shown in Western blot analysis. Functional enrichment analysis revealed the potential biological significance and signaling pathways of proteins supporting wound healing identified from ePDLSCs–exo. Furthermore, in vivo experiments showed ePDLSCs–exosomes impacted diabetic wound healing, with higher healing rates in the exosome‐treated group. Conclusion: Exosomes derived from ePDLSCs have demonstrated regenerative and healing properties, particularly in the context of tissue damage associated with diabetes.

24 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TBTeguh Budipitojo
Teguh Budipitojo
IPIrma Padeta
Irma Padeta
MPMedania Purwaningrum
Medania Purwaningrum
VBVista Budiariati
Vista Budiariati
NPNopadon Pirarat
Nopadon Pirarat
Adipose-derived mesenchymal stem cells (gAD-MSCs) are promising candidates for veterinary regenerative medicine, yet the characterization of gAD-MSCs from locally adapted Indonesian goat breeds remains limited. This study aimed to isolate and characterize gAD-MSCs from Peranakan Ettawa (PE) goats using tissue explant culture. Subcutaneous adipose tissue was collected from the base of the tail of healthy PE goats (n=3). Primary cell outgrowth from explants was observed by Day 5, displaying characteristic fibroblast-like, spindle-shaped morphology and strong plastic adherence. Serial passaging to Passage 3 (P3) yielded a morphologically stable, homogeneous cell population. Assessment of cellular metabolic activity via the resazurin assay demonstrated sustained cell viability and a statistically significant increase in metabolic activity between Day 3 and Day 5 ( p < 0.05). Furthermore, functional clonogenic capacity, evaluated using the colony-forming unit (CFU) assay, showed continuous temporal expansion of colonies over 14 days, yielding an average of 52.0 ± 4.1 colonies per dish. These findings confirm that expanded gAD-MSCs P3from PE goats maintain characteristic mesenchymal morphology, sustained metabolic activity, and clonogenic capacity. This work provides a baseline cellular profile of PE goat gAD-MSCs, supporting their potential use in veterinary regenerative medicine and tissue engineering.